Identification of novel predictor classifiers for inflammatory bowel disease by gene expression profiling
MetadatosMostrar el registro completo del ítem
AutorMontero Meléndez, Trinidad; Llor, Xavier; García-Planella, Esther; Perretti, Mauro; Suárez García, Antonio
Public Library of Science (PLOS)
BiomarkersBiopsyDiagnostic medicineGene expressionInflammationInflammatory bowel diseasesPrognosis
Montero-Meléndez, T.; et al. Identification of novel predictor classifiers for inflammatory bowel disease by gene expression profiling. Plos One, 8(10): e76235 (2013). [http://hdl.handle.net/10481/29690]
PatrocinadorThis study was funded by Fundació la Marató de TV3 (031531) and Spanish Health Ministry – Carlos III Institute (PI61550). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Background: Improvement of patient quality of life is the ultimate goal of biomedical research, particularly when dealing with complex, chronic and debilitating conditions such as inflammatory bowel disease (IBD). This is largely dependent on receiving an accurate and rapid diagnose, an effective treatment and in the prediction and prevention of side effects and complications. The low sensitivity and specificity of current markers burden their general use in the clinical practice. New biomarkers with accurate predictive ability are needed to achieve a personalized approach that take the inter-individual differences into consideration.Methods: We performed a high throughput approach using microarray gene expression profiling of colon pinch biopsies from IBD patients to identify predictive transcriptional signatures associated with intestinal inflammation, differential diagnosis (Crohn’s disease or ulcerative colitis), response to glucocorticoids (resistance and dependence) or prognosis (need for surgery). Class prediction was performed with self-validating Prophet software package.Results: Transcriptional profiling divided patients in two subgroups that associated with degree of inflammation. Class predictors were identified with predictive accuracy ranging from 67 to 100%. The expression accuracy was confirmed by real time-PCR quantification. Functional analysis of the predictor genes showed that they play a role in immune responses to bacteria (PTN, OLFM4 and LILRA2), autophagy and endocytocis processes (ATG16L1, DNAJC6, VPS26B, RABGEF1, ITSN1 and TMEM127) and glucocorticoid receptor degradation (STS and MMD2).Conclusions: We conclude that using analytical algorithms for class prediction discovery can be useful to uncover gene expression profiles and identify classifier genes with potential stratification utility of IBD patients, a major step towards personalized therapy.